EFB Home > News Room/Executive Biographies
News Room/Executive Biographies
| News Releases | Press Kit | Biographies | In the News | Image Gallery | Media Contacts |
|---|
Executive Biographies |
||
|---|---|---|
The European Federation of Biotechnology is governed by an Executive Board comprised of representatives from Industry and Academia. Reporters may obtain biographies of other executives by contacting the EFB Central Office.
|
||
 |
Em. Prof. Marc Van Montagu President, European Federation of Biotechnology Together with his colleague Prof. Jeff Schell, Em. Prof. Marc Van Montagu discovered the gene transfer mechanism between Agrobacterium and plants, which resulted in the development of methods to alter Agrobacterium into an efficient delivery system for gene engineering in plants. He has received numerous outstanding awards for his pioneering work. Read more. |
|
 |
Prof. Charlie Bryce Vice President, European Federation of Biotechnology Professor Bryce is Head of School of Life Sciences at Napier University, Chairman of the EFB Task Group on Education & Mobility, Secretary General of the European Association for Higher Education in Biotechnology and Visiting Professor at Zhengzhou University in China. Read more. |
|
 |
Prof. Brian Clark Vice President, European Federation of Biotechnology Brian Clark is Prof. of Biostructural Chemistry at the University of Åarhus in Denmark. His expertise involves decoding of the initiation of protein synthesis and the structural elucidation of transfer RNA. His current research interests centre on relation structure and function and identifying functional protein in functional genomics. Read more. |
|
 |
Prof. Jeff Cole Vice President, European Federation of Biotechnology Jeff Cole is Professor of Microbial Physiology and Biochemistry at the University of Birmingham and Deputy Editor in Chief of FEMS Microbiology Letters. His major scientific experiences include regulation of anaerobic bacterial metabolism, nitrate and nitrite reduction to ammonia, bacterial electron transfer pathways and pathogenicity of bacteria. Read more. |
|